
High-purity imidazole-based pharmaceutical intermediate used in the synthesis of Nilotinib and other tyrosine kinase inhibitor APIs.
High-purity pharmaceutical intermediate used in the synthesis of Nilotinib, tyrosine kinase inhibitors, and oncology active pharmaceutical ingredients.
Enquire About This Product| CAS Number | 641571-11-1 |
|---|---|
| Molecular Formula | C11H10F3N3 |
| Molecular Weight | 241.21 g/mol |
| Purity / Assay | 98.0% Min. (HPLC) |
| Appearance | White to Light Yellow Crystalline Powder |
| Packaging | 1 g / 5 g / 10 g / 25 g / 100 g / 500 g / 1 kg / Bulk Pack |
| Storage Conditions | Store in a tightly closed container at 2–8°C in a cool, dry place. Protect from moisture and light. |
| HS Code | 2933.99 |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline is a premium-quality pharmaceutical intermediate widely used in the synthesis of Nilotinib and other tyrosine kinase inhibitor active pharmaceutical ingredients. It is an important aromatic amine intermediate utilized in medicinal chemistry, oncology drug development, and pharmaceutical process optimization.
Manufactured under stringent quality control standards, this intermediate provides excellent purity, stability, and batch-to-batch consistency. Every batch undergoes comprehensive analytical testing to ensure compliance with pharmaceutical quality specifications.
Swapnroop Research Private Limited (SRPL) supplies high-quality 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline to pharmaceutical manufacturers, CROs, research organizations, and laboratories worldwide. Complete documentation including COA, MSDS, and technical support is available. Bulk quantities and customized packaging are offered upon request.
Pharmaceutical intermediate, Nilotinib intermediate, Tyrosine kinase inhibitor synthesis, Oncology API manufacturing, Medicinal chemistry, Process development, Analytical method development, Quality control laboratories, Research & Development.